CHRISTINE REITH: Open Payments
NPI 1538788393 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,700 in 159 payments from 20 companies in 2025. Trend: 2023 $112 · 2024 $876 · 2025 $3,700
Food & beverage: $3,700
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 38 | $1,089 |
| Insmed, Inc. | 21 | $489 |
| GENZYME CORPORATION | 7 | $412 |
| Pulmonx Corporation | 12 | $257 |
| Verona Pharma, Inc. | 16 | $215 |
| GlaxoSmithKline, LLC. | 13 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $168 |
| Viatris Specialty LLC | 11 | $143 |
| United Therapeutics Corporation | 5 | $143 |
| Amgen Inc. | 9 | $141 |
Products named: DUPIXENT, Arikayce, BREZTRI, FASENRA, TEZSPIRE, Ohtuvayre, CHARTIS CATHETER, YUPELRI.
Industry payments across OK — which companies pay providers there.
